Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PTEN Phosphohydrolase | 3 | 2022 | 107 | 1.040 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2020 | 4 | 0.770 |
Why?
|
| Phenylthiohydantoin | 1 | 2020 | 12 | 0.760 |
Why?
|
| Nitriles | 1 | 2020 | 68 | 0.750 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 69 | 0.730 |
Why?
|
| Benzamides | 1 | 2020 | 156 | 0.700 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 332 | 0.640 |
Why?
|
| Carcinoma | 4 | 2022 | 215 | 0.560 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 2550 | 0.520 |
Why?
|
| Apoptosis | 2 | 2020 | 1640 | 0.480 |
Why?
|
| Adenoma, Islet Cell | 1 | 2012 | 2 | 0.430 |
Why?
|
| Islets of Langerhans | 1 | 2012 | 87 | 0.410 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1174 | 0.380 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 334 | 0.380 |
Why?
|
| Cell Proliferation | 4 | 2020 | 1173 | 0.340 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 332 | 0.310 |
Why?
|
| Signal Transduction | 5 | 2020 | 2688 | 0.290 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 1533 | 0.270 |
Why?
|
| Mice | 11 | 2022 | 8472 | 0.270 |
Why?
|
| Animals | 16 | 2022 | 20877 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2015 | 90 | 0.260 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2017 | 163 | 0.240 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 2 | 2020 | 2 | 0.230 |
Why?
|
| BRCA1 Protein | 2 | 2020 | 30 | 0.230 |
Why?
|
| Endometrial Hyperplasia | 1 | 2022 | 4 | 0.210 |
Why?
|
| Cyclin D1 | 1 | 2022 | 37 | 0.210 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 46 | 0.210 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 80 | 0.200 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 46 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 79 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 87 | 0.190 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 95 | 0.190 |
Why?
|
| Fanconi Anemia | 1 | 2020 | 7 | 0.190 |
Why?
|
| Mice, Knockout | 3 | 2020 | 1692 | 0.190 |
Why?
|
| Tumor Burden | 1 | 2020 | 132 | 0.180 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 18 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 756 | 0.180 |
Why?
|
| E2F1 Transcription Factor | 2 | 2017 | 44 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2021 | 201 | 0.180 |
Why?
|
| E2F3 Transcription Factor | 2 | 2017 | 46 | 0.180 |
Why?
|
| Inflammation | 3 | 2022 | 1030 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2021 | 212 | 0.180 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 15 | 0.160 |
Why?
|
| Retinoblastoma Protein | 2 | 2015 | 75 | 0.160 |
Why?
|
| Estrogens | 1 | 2019 | 173 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2022 | 34 | 0.160 |
Why?
|
| Dog Diseases | 1 | 2018 | 45 | 0.160 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 52 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2019 | 159 | 0.150 |
Why?
|
| Genes, Neoplasm | 1 | 2017 | 18 | 0.150 |
Why?
|
| Gene Dosage | 1 | 2017 | 47 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2019 | 431 | 0.150 |
Why?
|
| E2F7 Transcription Factor | 1 | 2016 | 15 | 0.140 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 37 | 0.130 |
Why?
|
| Liver | 2 | 2022 | 1118 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2016 | 182 | 0.130 |
Why?
|
| E2F Transcription Factors | 1 | 2015 | 48 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2020 | 447 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2015 | 89 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2015 | 112 | 0.130 |
Why?
|
| Cell Compartmentation | 1 | 2014 | 41 | 0.130 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2014 | 21 | 0.120 |
Why?
|
| Adenomatous Polyps | 1 | 2014 | 18 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 307 | 0.120 |
Why?
|
| Intestines | 1 | 2014 | 114 | 0.120 |
Why?
|
| Female | 8 | 2022 | 38015 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 248 | 0.110 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2012 | 22 | 0.110 |
Why?
|
| Glucagon | 1 | 2012 | 22 | 0.110 |
Why?
|
| Somatostatin | 1 | 2012 | 36 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 104 | 0.110 |
Why?
|
| beta Catenin | 1 | 2012 | 73 | 0.100 |
Why?
|
| Adenoma | 1 | 2012 | 132 | 0.100 |
Why?
|
| Male | 6 | 2020 | 37281 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2222 | 0.080 |
Why?
|
| Insulin | 1 | 2012 | 617 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2019 | 235 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 1849 | 0.070 |
Why?
|
| Carcinogenesis | 2 | 2019 | 124 | 0.070 |
Why?
|
| Biopsy | 2 | 2019 | 539 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1032 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 946 | 0.060 |
Why?
|
| Rats | 1 | 2012 | 5300 | 0.060 |
Why?
|
| Genotype | 2 | 2016 | 785 | 0.060 |
Why?
|
| Diet, Western | 1 | 2022 | 17 | 0.050 |
Why?
|
| Threonine | 1 | 2022 | 47 | 0.050 |
Why?
|
| Mutation | 2 | 2019 | 1213 | 0.050 |
Why?
|
| Cross-Priming | 1 | 2021 | 10 | 0.050 |
Why?
|
| Glycosylation | 1 | 2022 | 185 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 76 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2022 | 284 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 118 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 211 | 0.050 |
Why?
|
| Humans | 7 | 2022 | 68525 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 20 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 265 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 397 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2019 | 89 | 0.040 |
Why?
|
| DNA Damage | 1 | 2020 | 190 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 294 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 194 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 142 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 84 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 301 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 179 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 110 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2019 | 489 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 902 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 490 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1034 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2020 | 384 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 34 | 0.040 |
Why?
|
| Protein Domains | 1 | 2016 | 74 | 0.040 |
Why?
|
| Collagen | 1 | 2019 | 636 | 0.030 |
Why?
|
| S Phase Cell Cycle Checkpoints | 1 | 2015 | 4 | 0.030 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2015 | 4 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 25 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2015 | 12 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 44 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 23 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 35 | 0.030 |
Why?
|
| E2F2 Transcription Factor | 1 | 2015 | 29 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 386 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 89 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 320 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 176 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2014 | 15 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 205 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2015 | 305 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 631 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
|
| DNA | 1 | 2016 | 597 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 901 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 2331 | 0.030 |
Why?
|
| Protein Binding | 1 | 2016 | 1027 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 562 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 219 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 614 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2004 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 231 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1070 | 0.030 |
Why?
|
| Models, Biological | 1 | 2014 | 981 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2673 | 0.020 |
Why?
|
| Quality of Life | 1 | 2018 | 1515 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1293 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 2175 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 5719 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 2790 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 4655 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 7264 | 0.020 |
Why?
|